Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
ACS Sustainable Chemistry & Engineering|February 1, 2021
Catalytic Conversion of Free Fatty Acids to Bio-Based Aromatics: A Model Investigation Using Oleic Acid and an H-ZSM-5/Al<sub>2</sub>O<sub>3</sub> CatalystSongbo He, Frederike Gerda Hiltje Klein, Thomas Sjouke Kramer, et al.Scientific Reports|November 4, 2020
Catalytic liquefaction of sewage sludge to small molecular weight chemicalsYuehu Wang, Feihong Tian, Peimei Guo, et al.ACS Sustainable Chemistry & Engineering|April 19, 2024
Enhanced Bio-BTX Formation by Catalytic Pyrolysis of Glycerol with <i>In Situ</i> Produced Toluene as the CofeedFukang Wang, Thomas Sjouke Kramer, Bin Yan, et al.European Journal of Medicinal Chemistry|December 4, 2017
Novel triazine dimers with potent antitrypanosomal activityMuthusamy Venkatraj, Irene G Salado, Jan Heeres, et al.Chemosphere|July 31, 2020
ZnO nanorod arrays assembled on activated carbon fibers for photocatalytic degradation: Characteristics and synergistic effectsSha Luo, Chunwei Liu, Sui Zhou, et al.ACS Sustainable Chemistry & Engineering|April 3, 2018
Synthesis of Bio-aromatics from Black Liquors Using Catalytic PyrolysisAndré Heeres, Niels Schenk, Inouk Muizebelt, et al.Journal of Medicinal Chemistry|March 18, 2005
Structure based activity prediction of HIV-1 reverse transcriptase inhibitorsMarc R de Jonge, Lucien M H Koymans, H Maarten Vinkers, et al.Bioorganic & Medicinal Chemistry Letters|October 23, 2012
Synthesis, evaluation and structure-activity relationships of triazine dimers as novel antiviral agentsMuthusamy Venkatraj, Kevin K Ariën, Jan Heeres, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|June 4, 2020
Triphenylphosphine-Based Covalent Organic Frameworks and Heterogeneous Rh-P-COFs CatalystsYubing Liu, Alla Dikhtiarenko, Naizhang Xu, et al.Antimicrobial Agents and Chemotherapy|November 25, 2004
TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1Koen Andries, Hilde Azijn, Theo Thielemans, et al.Pageof 4